Fouad Namouni Aprea Therapeutics, Inc. (APRE) insider trading activity
Fouad Namouni is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 4,610 shares of APRE, which is worth approximately $14,060. The most recent transaction as insider was on Jun 30, 2021, when has been sold 4,610 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.61K
0%
3M change
0%
12M change
Total Value Held
$14,060
Fouad Namouni Transaction History
Also insider at
FN
Fouad Namouni
Director
Cambridge, MA